Home > Insider Trading > Filing (0001209191-11-009468)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376260	P. Christopher Lowe	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545	Vp Of Administration And Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-02-11	80,997	$0.00	0	No	4	S	Indirect	By BioVest III

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By BioVest III

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	67,645	Direct
Common Stock	9,637	Indirect	By spouse

Footnotes

All shares of Common Stock of the Issuer held by Biovest were acquired upon conversion of Series A-1 Preferred Stock of the Issuer.
Mr. Lowe was a principal of BioVest III, which directly held the reported securities. On February 11, 2011, Mr. Lowe transferred his position as manager of the BioVest III for no consideration. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.